Search Results - "Accioly, Fernanda Andrade"
-
1
Prognostic factors in patients with advanced differentiated thyroid cancer treated with multikinase inhibitors - a single Brazilian center experience
Published in Archives of Endocrinology and Metabolism (03-11-2021)“…The aim of this study was to describe the real-world experience multikinase inhibitors (MKI) in the treatment advanced differentiated thyroid carcinoma (DTC)…”
Get full text
Journal Article -
2
Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review
Published in Archives of Endocrinology and Metabolism (01-04-2020)“…Most papillary thyroid carcinomas (PTC) harbor excellent prognosis. Although rare, distant metastases normally occur in lungs and/or bones. Here we describe a…”
Get full text
Journal Article -
3
An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study
Published in Thyroid (New York, N.Y.) (01-01-2023)“…Calcitonin measurement is widely used in the diagnosis, prognosis, and follow-up of patients with medullary thyroid carcinoma (MTC). The prognostic value of…”
Get more information
Journal Article -
4
External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long‐term local disease control?
Published in Head & neck (01-06-2024)“…Introduction Cervical disease control might be challenging in advanced thyroid cancer (DTC). Indications for cervical external beam radiation therapy (EBRT)…”
Get full text
Journal Article -
5
High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy
Published in Endocrine (01-08-2021)“…Purpose Around 10–27% of patients will present elevated thyroglobulin (Tg) levels and negative diagnostic whole-body scan (dxWBS) during differentiated thyroid…”
Get full text
Journal Article -
6
Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients
Published in Endocrine (01-06-2024)“…Introduction Differentiated thyroid carcinoma (DTC) is a rare oncological disease in the pediatric population, presenting with a more aggressive form…”
Get full text
Journal Article -
7
Neutrophil-to-lymphocyte ratio as an independent factor for worse prognosis in radioiodine refractory thyroid cancer patients
Published in Endocrine (01-07-2023)“…Purpose This study aimed to evaluate neutrophil to lymphocyte ratio (NLR) as a laboratory biomarker in radioactive iodine-refractory (RAIR) locally advanced…”
Get full text
Journal Article -
8
Pregnancy has no significant impact on the prognosis of differentiated thyroid cancer
Published in Archives of Endocrinology and Metabolism (24-11-2021)“…To evaluate the impact of pregnancy on differentiated thyroid carcinomas (DTC) behavior. Retrospective study of patients diagnosed with DTC before or during…”
Get full text
Journal Article -
9
Puberty and sex in pediatric thyroid cancer: could expression of estrogen and progesterone receptors affect prognosis?
Published in European thyroid journal (01-04-2022)“…Objective A sharp increase in pediatric thyroid cancer incidence is observed during adolescence, driven mainly by girls. Differences in disease presentation…”
Get full text
Journal Article -
10
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma
Published in Endocrine (01-12-2017)“…Purpose Medullary thyroid carcinoma (MTC) is a malignant neoplasm of parafollicular cells. Because it is a neuroendocrine tumor, it has known somatostatin…”
Get full text
Journal Article -
11
Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer
Published in European thyroid journal (01-04-2024)“…Treatment of patients with pediatric differentiated thyroid cancer (DTC) often involves radioiodine (RAI), which is associated with increased risks of short-…”
Get full text
Journal Article -
12
TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
Published in Endocrine (01-09-2018)“…Purpose Evaluate the impact of TERTp mutation on the outcomes after initial treatment of 45 patients with thyroid carcinomas derived from follicular cells…”
Get full text
Journal Article -
13
Clinical Outcomes After Radioiodine Therapy, According to the Method of Preparation by Recombinant TSH vs. Endogenous Hypothyroidism, in Thyroid Cancer Patients at Intermediate-High Risk of Recurrence
Published in Frontiers in nuclear medicine (2021)“…To effectively treat differentiated thyroid carcinoma (DTC) with radioiodine therapy (RAI), it is necessary to raise serum thyrotropin levels, either by…”
Get full text
Journal Article